Cargando…
The cytokine interleukin-26 as a biomarker in pediatric asthma
In this pilot study, we examined associations between local interleukin (IL)-26, disease severity and biomarkers of Th2-mediated inflammation in a well-defined cohort of pediatric patients (14 years median age, 41 % females) with controlled (n = 28) or uncontrolled (n = 48) asthma. Sputum IL-26 prot...
Autores principales: | Konradsen, Jon R., Nordlund, Björn, Levänen, Bettina, Hedlin, Gunilla, Linden, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815075/ https://www.ncbi.nlm.nih.gov/pubmed/27029915 http://dx.doi.org/10.1186/s12931-016-0351-6 |
Ejemplares similares
-
YKL‐40 is a proposed biomarker of inflammation and remodelling elevated in children with bronchopulmonary dysplasia compared to asthma
por: James, Anna J., et al.
Publicado: (2020) -
The neutrophil-mobilizing cytokine interleukin-26 in the airways of long-term tobacco smokers
por: Che, Karlhans Fru, et al.
Publicado: (2018) -
Biomarkers for the Phenotyping and Monitoring of Asthma in Children
por: James, Anna, et al.
Publicado: (2016) -
Longitudinal eosinophil‐derived neurotoxin measurements and asthma development in preschool wheezers
por: Chakraborty, Sandip, et al.
Publicado: (2022) -
Impact of tobacco smoking on cytokine signaling via interleukin-17A in the peripheral airways
por: Levänen, Bettina, et al.
Publicado: (2016)